# TherapeuticsMD, Inc.: Form 8-K, filed Dec 5, 2024

- Company: [TherapeuticsMD, Inc.](/companies/txmd.md) (CIK 25743)
- Form: 8-K
- Filed: 2024-12-05
- Accepted by EDGAR: Dec 5, 2024, 17:15 ET
- Period: 2024-12-05
- Accession: 0001213900-24-106095
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/25743/000121390024106095/ea0223856-8k_therap.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/25743/000121390024106095/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/25743/000121390024106095/ea0223856-8k_therap.htm

Filed Dec 5, 2024.
Source: SEC EDGAR, the filing index for accession 0001213900-24-106095. Last ingested by Listed: Oct 24, 2026, 14:52 ET. No prices; not investment advice.
